Skip to main content
. Author manuscript; available in PMC: 2021 Mar 15.
Published in final edited form as: Exp Neurol. 2020 Jan 18;327:113207. doi: 10.1016/j.expneurol.2020.113207

Figure 5. Loss of Sarm1 reduces astrogliosis after rmCHI.

Figure 5.

Representative high magnification images of GFAP immunoreactivity in the white matter tracts (corpus callosum, cingulum, alveus, and fimbria of the fornix) of WT sham, WT rmCHI, Sarm1−/− sham, and Sarm1−/− rmCHI animals six months after injury or sham surgery. Summary data of the integrated fluorescent intensity of GFAP immunoreactivity in the white matter tracts. Data (mean ± SEM) are shown as the percent change relative to the wild-type sham group. *p < 0.05 in two-way ANOVA with Bonferroni’s multiple comparisons. CA1: Cornu Ammonis 1; CC: corpus callosum; Ctx: cortex; HC: hippocampal commissure.